1. |
Herbal remedy important modern medicine? |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 2-2
&NA;,
Preview
|
PDF (670KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
2. |
US pharmacists urged to ‘get their act together’ |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 3-3
Sean Henahan,
Preview
|
PDF (691KB)
|
|
摘要:
US clinical pharmacists have a major role to play in the ‘brave new world’ of healthcare reform, but so far have been slow to take up the challenge, the Executive Vice President of the American Pharmaceutical Association, told the Winter Forum of the American College of Clinical Pharmacy meeting held in San Diego earlier this month.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
3. |
Antibacterials recommended forH. pylori-infected ulcers |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 4-4
&NA;,
Preview
|
PDF (674KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
4. |
Views in the news |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 5-5
&NA;,
Preview
|
PDF (638KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
5. |
Did you know …? |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 6-6
&NA;,
Preview
|
PDF (705KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
6. |
Cost considerations … |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 7-7
&NA;,
Preview
|
PDF (610KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
7. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 8-8
&NA;,
Preview
|
PDF (667KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
8. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 9-9
&NA;,
Preview
|
PDF (642KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
9. |
Mental development helped by fibroblast growth factor |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 10-10
&NA;,
Preview
|
PDF (660KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
10. |
New agent competes with triple therapy inH. pylorieradication |
|
Inpharma Weekly,
Volume &NA;,
Issue 925,
1994,
Page 11-11
Robert Short,
Preview
|
PDF (651KB)
|
|
摘要:
With recent results showing thatHelicobacter pylorieradication really does prevent stomach ulcers, Glaxo could be onto a winner with their new agent, ranitidine bismuth citrate. This single chemical molecule has been developed for use as monotherapy or in combination with antibacterials, and is likely to provide fierce competition for the currently-used triple therapy. Glaxo plans to file for regulatory approval for this drug later this year.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|